To Pace or Not to Pace for Neurally Mediated Syncope: Do We Know the Answer? A Negative View

  • O. Oseroff
Conference paper


The vasovagal or neurally mediated syncope (NMS) is a common disorder of the autonomie cardiovascular regulation, showing a substantial physical and social morbidity. This complex syndrome usually is caused by inappropriate reflex vasodilatation and bradycardia, of sporadic nature. However, a small percentage of patients present NMS as a chronic and recurrent disorder with an important impact on their quality of life. In such circumstances, as NMS becomes a risk for severe trauma, an adequate clinical assessment and careful selection of specific treatment is necessary.


Cardiac Pace Vasovagal Syncope Dual Chamber Pacemaker Therapy Carotid Sinus Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lacroix D, Kouakam C, Klug D et al (1997) Asystolic cardiac arrest during Head-Up Tilt Test: incidence and therapeutic implications. PACE 20:2746–2754PubMedCrossRefGoogle Scholar
  2. 2.
    Moya A, Brignole M, Menozzi C et al (2001) for the ISSUE Investigators. Mechanism of syncope in patients with isolated syncope and in patients with Tilt-positive syncope. Circulation 104:1261–1267Google Scholar
  3. 3.
    Petersen M, Chamberlain-Webber R, Fitzpatrick A et al (1994) Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 71:274–281PubMedCrossRefGoogle Scholar
  4. 4.
    Bendit D, Sutton R, Gammege M et al (1997) Clinical experience with Thera DR Rate-Drop Response pacing algorithm in carotid sinus syndrome and vasovagal syncope. PACE 20:832–839CrossRefGoogle Scholar
  5. 5.
    Shah C, Thakur R, Xei B et al (1999) Dual chamber pacing for neurally mediated syncope with prominent cardioinhibitory component. PACE 22:999–1003PubMedCrossRefGoogle Scholar
  6. 6.
    Ammirati F, Colivicchi F, Toscano S et al (1998) DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal Syncope. PACE 21:2178–2181PubMedCrossRefGoogle Scholar
  7. 7.
    Connolly S, Sheldon R, Roberts R et al (1999) The North American Vasovagal Pacemaker Study (VPS). A randomised trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20CrossRefGoogle Scholar
  8. 8.
    Sutton R, Brignole M, Menozzi C et al (2000) for the VASIS Investigators. Dual-Chamber pacing in the treatment of neurally mediated Tilt-Positive cardioinhibitory Syncope. Pacemaker versus no therapy: A multicenter randomised study. Circulation 102:294–299Google Scholar
  9. 9.
    Ammirati F, Colivicchi F, Santini M et al (2001) for the SYDIT Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter, randomized, controlled trial. Circulation 104:52–57Google Scholar
  10. 10.
    Connolly S, Sheldon R, Thorpe K et al (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. JAMA 289:2224–2229PubMedCrossRefGoogle Scholar
  11. 11.
    Sheldon R, Rose S, Flanagan P et al (1996) Multivariate predictors of syncope recurrence in drug-free patients following a positive tilt table test. Circulation 93:973–981PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • O. Oseroff
    • 1
  1. 1.Department of CardiologyHospital CastexBuenos AiresArgentina

Personalised recommendations